Viral Cover-Up: SARS-CoV-2 Cap Offers New Target for Antivir

Howard Hughes Medical Institute (HHMI) Investigator Vincent Tagliabracci and his team has delineated key steps by which SARS-CoV-2 disguises one end of its genome. Blocking this process could lead to new treatments of COVID-19.

Related Keywords

Adam Osinski , Vincent Tagliabracci , Warner Greene , Patrick Eyers , University Of Texas Southwestern Medical Center , Howard Hughes Medical Institute Investigator , University Of Liverpool , Texas Southwestern Medical , Gina Park , Gladstone Institutes , Howard Hughes Medical Institute , Ohmi , Hhmi Investigator , Coronavirus , Covid 19 , Delta , Micron , Ars Cov 2 , Ana Cap , Na Genome , Remdesivir , Olnupiravir , Nirmatrelvir , Combination Therapy , Combo Therapy , Rna , Inase , Iran , Nina Park , Antivirals , Iochemistry , Structural Biology ,